Grant: Fellowship - Priority Announcement - HIV/AIDS and/or STBBI
University of British Columbia
$90,000.00
Impact of COVID-19 pandemic on health care services related to hepatitis B
EF 2023-24
Résumé
Hepatitis B infection affects about 216,000 people in Canada. While vaccines and effective treatments for achieving viral suppression are available, chronic hepatitis B infection remains a cause of serious illness and death. The COVID-19 pandemic led to disruptions in health care services. However, the impact of the pandemic on testing and treatment for hepatitis B is not well understood.
This study will investigate the impact of the COVID-19 pandemic and related policies on testing and treatment for hepatitis B from April 2020 to December 2022 in British Columbia (BC). We will look at impacts on the full population of BC and impacts for sex and age groups, prenatal women, people who inject drugs, and immigrants.
This study will provide information to help make policy aimed at eliminating hepatitis B as a public health threat by 2030. It will also provide information to help make policy to deliver health care services related to hepatitis B during future health care system disruptions such as pandemics.
Programme
Fellowship - Priority Announcement - HIV/AIDS and/or STBBI
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
497725
Name
Morrow Richard
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Impact of COVID-19 pandemic on health care services related to hepatitis B
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - HIV/AIDS and/or STBBI
Keyworddelim
Covid-19 Pandemic; Hepatitis B; Immigrants; Interrupted Time Series Analysis; People Who Inject Drugs; Sexually Transmitted And Blood-Borne Infections
Abstract
Hepatitis B infection affects about 216,000 people in Canada. While vaccines and effective treatments for achieving viral suppression are available, chronic hepatitis B infection remains a cause of serious illness and death. The COVID-19 pandemic led to disruptions in health care services. However, the impact of the pandemic on testing and treatment for hepatitis B is not well understood.
This study will investigate the impact of the COVID-19 pandemic and related policies on testing and treatment for hepatitis B from April 2020 to December 2022 in British Columbia (BC). We will look at impacts on the full population of BC and impacts for sex and age groups, prenatal women, people who inject drugs, and immigrants.
This study will provide information to help make policy aimed at eliminating hepatitis B as a public health threat by 2030. It will also provide information to help make policy to deliver health care services related to hepatitis B during future health care system disruptions such as pandemics.
Competitiondate
202310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Morrow, Richard
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~
